Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
16.19
-0.32 (-1.91%)
Jul 3, 2025, 1:00 PM - Market closed
Pelthos Therapeutics Statistics
Total Valuation
PTHS has a market cap or net worth of $10.68 million. The enterprise value is $13.05 million.
Market Cap | 10.68M |
Enterprise Value | 13.05M |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PTHS has 659,585 shares outstanding. The number of shares has increased by 173.25% in one year.
Current Share Class | 659,585 |
Shares Outstanding | 659,585 |
Shares Change (YoY) | +173.25% |
Shares Change (QoQ) | +1.51% |
Owned by Insiders (%) | 8.36% |
Owned by Institutions (%) | 2.89% |
Float | 207,541 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18
Current Ratio | 0.18 |
Quick Ratio | 0.03 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -25.62 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -188.95% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 178.07% |
Revenue Per Employee | n/a |
Profits Per Employee | -$669,147 |
Employee Count | 11 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.44% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +27.44% |
50-Day Moving Average | 11.70 |
200-Day Moving Average | 11.65 |
Relative Strength Index (RSI) | 70.27 |
Average Volume (20 Days) | 17,392 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | 272,308 |
Operating Income | -7.47M |
Pretax Income | n/a |
Net Income | -7.36M |
EBITDA | n/a |
EBIT | -7.47M |
Earnings Per Share (EPS) | -$12.40 |
Balance Sheet
The company has $131,317 in cash and $2.50 million in debt, giving a net cash position of -$2.37 million or -$3.60 per share.
Cash & Cash Equivalents | 131,317 |
Total Debt | 2.50M |
Net Cash | -2.37M |
Net Cash Per Share | -$3.60 |
Equity (Book Value) | -4.20M |
Book Value Per Share | -6.79 |
Working Capital | -4.20M |
Cash Flow
Operating Cash Flow | -4.43M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PTHS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -173.25% |
Shareholder Yield | -173.25% |
Earnings Yield | -68.95% |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 2, 2025. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Jul 2, 2025 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |